Advertisement

Topics

Challenge the Buyout: Ademi & O’Reilly, LLP Investigates Whether Precision Castparts Corp. Has Obtained a Fair Price in Its Sale to Berkshire Hathaway

20:00 EDT 9 Aug 2015 | Globe Newswire

MILWAUKEE, Aug. 10, 2015 (GLOBE NEWSWIRE) -- We are investigating the Board of Directors of Precision Castparts for possible breaches of fiduciary duty and other violations of state law in connection with the sale of Precision Castparts to Berkshire.

Click here to learn how to join the action: http://www.ademilaw.com/case/precision or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

Precision Castparts’s long-term financial outlook is positive and yet shareholders will receive only the equivalent of approximately $235 per share.  Berkshire is well aware of Precision Castparts’s improving financial metrics and is purchasing Precision Castparts at a substantial discount.   The merger agreement unreasonably limits prospective bids by (i) prohibiting solicitation of any further bids, and (ii) imposing a termination penalty should Precision Castparts receive and accept a superior bid.  Precision Castparts’s insiders and their affiliates own significant stock, and will receive millions of dollars as part of change of control arrangements.  These insiders can unduly influence a sale of Precision Castparts, which may not be in the best interests of non-insider shareholders.  Our investigation centers on the conduct of Precision Castparts’s Board of Directors, who have unanimously approved the transaction, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Precision Castparts given its current financial condition and prospects. 

If you own shares of Precision Castparts and wish to obtain additional information, please contact Guri Ademi either at gademi@ademilaw.com or toll-free: 866-264-3995, http://www.ademilaw.com/case/Precision Castparts.                                 

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country.  For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Ademi & O’Reilly, LLP
Guri Ademi
3620 East Layton Ave.
Cudahy, WI 53110
Toll Free: (866) 264-3995
Fax: (414) 482-8001
www.ademilaw.com
NEXT ARTICLE

More From BioPortfolio on "Challenge the Buyout: Ademi & O’Reilly, LLP Investigates Whether Precision Castparts Corp. Has Obtained a Fair Price in Its Sale to Berkshire Hathaway"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...